0000950142-19-000200.txt : 20190211 0000950142-19-000200.hdr.sgml : 20190211 20190211160806 ACCESSION NUMBER: 0000950142-19-000200 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20181231 FILED AS OF DATE: 20190211 DATE AS OF CHANGE: 20190211 EFFECTIVENESS DATE: 20190211 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Aisling Capital LLC CENTRAL INDEX KEY: 0001571076 IRS NUMBER: 010849048 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-15878 FILM NUMBER: 19585444 BUSINESS ADDRESS: STREET 1: 888 SEVENTH AVENUE, 12TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10106 BUSINESS PHONE: 212-651-6372 MAIL ADDRESS: STREET 1: 888 SEVENTH AVENUE, 12TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10106 13F-HR 1 primary_doc.xml 13F-HR LIVE false false false 0001571076 XXXXXXXX 12-31-2018 12-31-2018 false Aisling Capital LLC

888 Seventh Avenue, 12th Floor New York NY 10106

13F HOLDINGS REPORT 028-15878 N Robert Wenzel 212-651-6374 /s/ Robert Wenzel New York NY 02-11-2019 0 9 353143 INFORMATION TABLE 2 infotable.xml ADMA BIOLOGICS INC COM 000899104 8624 3608171 SH SOLE 3608171 0 0 AIMMUNE THERAPEUTICS INC. COM 00900T107 47601 1990000 SH SOLE 1990000 0 0 CHIMERIX INC. COM 16934W106 1215 472943 SH SOLE 472943 0 0 CIDARA THERAPEUTICS INC. COM 171757107 2400 1021148 SH SOLE 1021148 0 0 LOXO ONCOLOGY INC COM 548862101 285592 2038920 SH SOLE 2038920 0 0 PERNIX THERAPEUTICS HLDGS IN COM NEW 71426V306 88 210000 SH SOLE 210000 0 0 PERNIX THERAPEUTICS HLDGS INC DBCV 4.250% 4/0 71426VAK4 16 2500000 PRN SOLE 2500000 0 0 TRANSENTERIX INC. COM NEW 89366M201 5400 2389352 SH SOLE 2389352 0 0 VIEWRAY INC. COM 92672L107 2207 363640 SH SOLE 363640 0 0